3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Sell
14
DHC Quote, Financials, Valuation and Earnings
Last price:
$2.53
Seasonality move
:
1.34%
Day range:
$2.36 - $2.48
52-week range:
$2.01 - $4.24
Dividend yield:
1.67%
P/E ratio:
--
P/S ratio:
0.38x
P/B ratio:
0.30x
Volume:
909.8K
Avg. volume:
952K
1-year change:
-2.44%
Market cap:
$579.1M
Revenue:
$1.5B
EPS (TTM):
-$1.55
Analysts' Opinion
-
Consensus RatingDiversified Healthcare Trust has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $2.00, Diversified Healthcare Trust has an estimated downside of -16.67% from its current price of $2.40.
-
Price Target UpsideAccording to analysts, the highest upside price target is $2.00 representing -100% upside increase from its current price of $2.40.
Fair Value
-
According to the consensus of 1 analyst, Diversified Healthcare Trust has -16.67% downside to fair value with a price target of $2.00 per share.
DHC vs. S&P 500
-
Over the past 5 trading days, Diversified Healthcare Trust has underperformed the S&P 500 by -0.69% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Diversified Healthcare Trust does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Diversified Healthcare Trust has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Diversified Healthcare Trust reported revenues of $379.6M.
Earnings Growth
-
Diversified Healthcare Trust earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Diversified Healthcare Trust reported earnings per share of -$0.37.
Enterprise value:
3.3B
EV / Invested capital:
--
Price / LTM sales:
0.38x
EV / EBIT:
--
EV / Revenue:
2.24x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
29.81x
Price / Operating cash flow:
5.12x
Enterprise value / EBITDA:
22.46x
Gross Profit (TTM):
$258.9M
Return On Assets:
-6.97%
Net Income Margin (TTM):
-24.76%
Return On Equity:
-17.23%
Return On Invested Capital:
-7.43%
Operating Margin:
-3.11%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.3B | $1.4B | $1.5B | $361.5M | $379.6M | |
| Gross Profit | $174.5M | $236.2M | $258.9M | $58.1M | $64.4M | |
| Operating Income | -$91.2M | -$74.1M | -$52.6M | -$31.5M | -$11.8M | |
| EBITDA | $427.8M | $203.3M | $148.9M | $52.6M | $38.1M | |
| Diluted EPS | -$0.06 | -$1.23 | -$1.55 | -$0.43 | -$0.37 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $203.3M | $1B | $697.4M | $262.5M | $430.2M | |
| Total Assets | $6.5B | $6.6B | $6B | $5.4B | $5.1B | |
| Current Liabilities | $51.8M | $838.1M | $734.6M | $29.9M | $38.1M | |
| Total Liabilities | $3.9B | $4B | $3.4B | $3.1B | $3.2B | |
| Total Equity | $2.6B | $2.7B | $2.6B | $2.3B | $2B | |
| Total Debt | $2.8B | $3.6B | $3B | $2.8B | $2.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$40.4M | $10.5M | $112.2M | -$7.2M | $18.2M | |
| Cash From Investing | $387.7M | -$202.1M | -$187M | -$51.3M | -$66.1M | |
| Cash From Financing | -$676M | -$249.7M | -$22.3M | $26.3M | -$63.6M | |
| Free Cash Flow | -$40.4M | $10.5M | $112.2M | -$7.2M | $18.2M | |
DHC
Sector
Market Cap
$579.1M
$1B
Price % of 52-Week High
56.6%
80.89%
Dividend Yield
1.67%
3.28%
Shareholder Yield
-3.13%
3.41%
1-Year Price Total Return
-2.44%
-2.15%
Beta (5-Year)
2.019
0.770
Dividend yield:
1.67%
Annualized payout:
$0.04
Payout ratio:
-2.6%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.48
200-day SMA
Sell
Level
$2.93
Bollinger Bands (100)
Sell
Level
2.24 - 2.78
Chaikin Money Flow
Sell
Level
-3.8M
20-day SMA
Sell
Level
$2.57
Relative Strength Index (RSI14)
Sell
Level
40.64
ADX Line
Sell
Level
35
Williams %R
Buy
Level
-86.4198
50-day SMA
Sell
Level
$2.52
MACD (12, 26)
Buy
Level
0.68
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Sell
Level
-6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.326)
Sell
CA Score
(Annual)
Level (-0.9027)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.718)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.
Stock Forecast FAQ
In the current month, DHC has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The DHC average analyst price target in the past 3 months is $2.00.
-
Where Will Diversified Healthcare Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Diversified Healthcare Trust share price will drop to $2.00 per share over the next 12 months.
-
What Do Analysts Say About Diversified Healthcare Trust?
Analysts are divided on their view about Diversified Healthcare Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Diversified Healthcare Trust is a Sell and believe this share price will rise from its current level to $2.00.
-
What Is Diversified Healthcare Trust's Price Target?
The price target for Diversified Healthcare Trust over the next 1-year time period is forecast to be $2.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is DHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Diversified Healthcare Trust is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of DHC?
You can purchase shares of Diversified Healthcare Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Diversified Healthcare Trust shares.
-
What Is The Diversified Healthcare Trust Share Price Today?
Diversified Healthcare Trust was last trading at $2.53 per share. This represents the most recent stock quote for Diversified Healthcare Trust. Yesterday, Diversified Healthcare Trust closed at $2.40 per share.
-
How To Buy Diversified Healthcare Trust Stock Online?
In order to purchase Diversified Healthcare Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 18.2% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 5.56% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 5.43% over the past day.
